New America High Income Fund
HYB · NYSE
About HYB
- Employees
- 0
- Headquarters
- Boston, Massachusetts
- Listed
- Feb 19, 1988
- Sector
- N/A
- Industry
- N/A
- Website
- newamerica-hyb.com
HYB key statistics
- Market cap
- 191.67M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 457
- Volume
- 321
- Open price
- $25.00
- High today
- $25.05
- Low today
- $25.03
- 52 Week high
- $25.02
- 52 Week low
- $25.01
New America High Income Fund (HYB) at a glance
New America High Income Fund (HYB) last traded at $25.05, with a market cap of 191.67M and a price-to-earnings ratio of 0.00.
Today the stock has traded between $25.03 and $25.05. The current price is 0.1% above the day's low and 0.0% below its high.
Volume so far is 321 shares, below the average of 457 shares a day.
Over the past year New America High Income Fund has ranged from $25.01 to $25.02, and now sits 332% of the way up that range.
HYB news
- Press releasePRNewswire
- Press releaseBusiness Wire
Saba Capital Reaches Agreement With The New America High Income Fund
Most active stocks
Highest trading volume today
- SHFSSHF Holdings$0.0245+54.09%
- RDARRaadr$0.0002+0.00%
- TIPSTianrong Internet Products & Services$0.0004−55.56%
- RCTRedCloud Holdings$0.034+10.75%
- NVDANVIDIA$173.73+2.92%
- SOXLDirexion Shares ETF Trust$66.03+17.78%
- SCKTSocket Mobile$0.4643+84.91%
- CENNCenntro$0.1463+19.23%
- INLFINLIF$0.6999+28.16%
- CRWVCoreWeave$60.77+24.71%
- BDMDBaird Medical Investment Holdings$0.104+7.22%
Newly listed
Companies that went public in the past six weeks
- NARANarragansett Bancorp$10.60−1.30%
- ASPEAspen Neuroscience$13.82+7.88%
- BBTXBambusa Therapeutics$17.16+0.65%
- GBCGEORGIA BANKING$33.84+0.03%
- BHAIUBHAV Acquisition Corp II$10.00−0.15%
- SCQCUSPACCircle Acquisition$10.01−0.10%
- LYCALycia Therapeutics$31.44+0.45%
- DAVIDAVION HEALTHCARE$1.39−12.03%
- TCXBTCGX Acquisition Corp. II$10.25+0.89%
- CTYCITY THERAPEUTICS$17.01−13.30%
- IAMIambic Therapeutics$15.39+4.09%
- AMROAmaero$6.07+9.47%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.